Previous 10 | Next 10 |
BATON ROUGE, La., March 23, 2023 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, and high-acuity care, supports the findings from the NORC at the University of Chicago study released by the National Association for Home Care & Hospice (NAHC) and ...
2023-03-15 13:45:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-03-13 17:38:29 ET Amedisys ( NASDAQ: AMED ) on Monday said it had named Richard Ashworth as its president and CEO. Ashworth will assume the role from current CEO Paul Kusserow on April 10, AMED said in a statement . Kusserow will remain chairman of A...
BATON ROUGE, La., March 13, 2023 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), the leading provider of quality home health, hospice, and high-acuity care services, today announced that its Board of Directors has named Richard Ashworth as President, Chief Executive Officer, and member of the ...
Amedisys and nVoq Present Outcomes from Speech Recognition Study at PALTC23 Conference PR Newswire BOULDER, Colo. , March 9, 2023 /PRNewswire/ -- nVoq Incorporated, the in-home healthcare industry's leading provider of HIPAA compliant speech recognition solutions...
2023-03-05 21:45:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Summary Amedisys delivered a mixed set of Q4 numbers, with upsides vs consensus. In more detail, growth was inconsistent across key divisions and further down the P&L. Returns on capital below the hurdle rate remain as a key tension point. Looks overpriced at 26x earnings. R...
Amedisys, Inc. (AMED) Q4 2022 Earnings Conference Call February 16, 2023, 11:00 ET Company Participants Nick Muscato - Chief Strategy Officer Paul Kusserow - Chairman & CEO Scott Ginn - EVP, CFO & Acting COO Adam Holton - Chief People Officer Conferen...
The following slide deck was published by Amedisys, Inc. in conjunction with their 2022 Q4 earnings call. For further details see: Amedisys, Inc. 2022 Q4 - Results - Earnings Call Presentation
Amedisys ( NASDAQ: AMED ) said on Wednesday it had signed an agreement to divest its personal care division to HouseWorks inorder to focus on its Home Health, Hospice and High Acuity Care units. HouseWorks, in partnership with eCaring, provides mission critical software and ...
News, Short Squeeze, Breakout and More Instantly...
BATON ROUGE, La., July 24, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and six-month periods ended June 30, 2024. Three-Month Periods Ended June 30, 2024 and 2023 Net service revenue increased $38.2 million to...
Alkermes plc (ALKS) is expected to report $0.64 for Q2 2024 Acerinox ADR (ANIOY) is expected to report for Q2 2024 Allegion plc (ALLE) is expected to report $1.77 for Q2 2024 Deutsche Bank AG (DB) is expected to report $0.43 for Q2 2024 Pathward Financial Inc. (CASH) is expected t...
Amedisys, Inc. (NASDAQ: AMED) has caught the attention of the investment community today with its bullish price action. The company's shares have moved 3.74% on the day to $95.23. Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates thr...